Assistant Professor Curtis Thorne, PhD in collaboration with Dr. Koenraad Van Doorslaer were awarded a Technology and Research Initiative Fund (TRIF) grant from the BIO5 Institute. The goal of their project is to rapidly test bioactive, clinically actionable and structurally diverse compounds for their activity in disrupting COVID-19 replication in bronchial tissue models. To accomplish this, Thorne and Van Doorslaer are developing a novel high-throughput assay to tract viral replication at the sub-cellular level with plans to make all data available in realtime to the international scientific community.
